| NCT Number | NCT07190105 |
| Lead Sponsor | Leidos Life Sciences |
| Conditions | Long COVID Symptoms |
| Enrollment | 546 participants |
| Start Date | 2025-10-27 |
| Primary Completion | 2025-12-11 (estimated) |
| Study Completion | 2025-12-11 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-07 |